Literature DB >> 28419687

Skeletal muscle analyses: agreement between non-contrast and contrast CT scan measurements of skeletal muscle area and mean muscle attenuation.

Anne van der Werf1, Ingeborg M Dekker1, Martijn R Meijerink2, Nicolette J Wierdsma1, Marian A E de van der Schueren1, Jacqueline A E Langius1.   

Abstract

Low skeletal muscle area (SMA) and muscle radiation attenuation (MRA) have been associated with poor prognosis in various patient populations. Both non-contrast and contrast CT scans are used to determine SMA and MRA. The effect of the use of a contrast agent on SMA and MRA is unknown. Therefore, we investigated agreement between these two scan options. SMA and MRA of 41 healthy individuals were analysed on a paired non-contrast and contrast single CT scan, and agreement between paired scan results was assessed with use of Bland-Altman plots, intraclass correlation coefficients (ICCs), standard error of measurements (SEM) and smallest detectable differences at a 95% confidence level (SDD95 ). Analyses were stratified by tube voltage. Difference in SMA between non-contrast and contrast scans made with a different tube voltage was 7·0 ± 7·5 cm2 ; for scans made with the same tube voltage this was 2·3 ± 1·7 cm2 . Agreement was excellent for both methods: ICC: 0·952, SEM: 7·2 cm2 , SDD95 : 19·9 cm2 and ICC: 0·997, SEM: 2·0 cm2 , SDD95 : 5·6 cm2 , respectively. MRA of scans made with a different tube voltage differed 1·3 ± 11·3 HU, and agreement was poor (ICC: 0·207, SEM: 7·9 HU, SDD95 : 21·8 HU). For scans made with the same tube voltage the difference was 6·7 ± 3·2 HU, and agreement was good (ICC: 0·682, SEM: 5·3 HU, SDD95 : 14·6 HU). In conclusion, SMA and MRA can be slightly influenced by the use of contrast agent. To minimise measurement error, image acquisition parameters of the scans should be similar.
© 2017 The Authors. Clinical Physiology and Functional Imaging published by John Wiley & Sons Ltd. on behalf of Scandinavian Society of Clinical Physiology and Nuclear Medicine.

Entities:  

Keywords:  computed tomography; contrast agent; muscle density; muscle mass; single slice

Mesh:

Substances:

Year:  2017        PMID: 28419687     DOI: 10.1111/cpf.12422

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  16 in total

1.  Change in Skeletal Muscle Following Resection of Stage I-III Colorectal Cancer is Predictive of Poor Survival: A Cohort Study.

Authors:  Jessica J Hopkins; Rebecca Reif; David Bigam; Vickie E Baracos; Dean T Eurich; Michael M Sawyer
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

2.  Quantifying Sarcopenia Reference Values Using Lumbar and Thoracic Muscle Areas in a Healthy Population.

Authors:  B A Derstine; S A Holcombe; R L Goulson; B E Ross; N C Wang; J A Sullivan; G L Su; S C Wang
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

3.  Reply to comment on "Sarcopenia is a prognostic factor for overall survival in elderly patients with head and neck cancer".

Authors:  N Chargi; S I Bril; P A de Jong; M H Emmelot-Vonk; Remco de Bree
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-08       Impact factor: 2.503

4.  Influence of Contrast Administration on Computed Tomography-Based Analysis of Visceral Adipose and Skeletal Muscle Tissue in Clear Cell Renal Cell Carcinoma.

Authors:  Michael T Paris; Helena F Furberg; Stacey Petruzella; Oguz Akin; Andreas M Hötker; Marina Mourtzakis
Journal:  JPEN J Parenter Enteral Nutr       Date:  2018-01-19       Impact factor: 4.016

5.  Comparison between skeletal muscle and adipose tissue measurements with high-dose CT and low-dose attenuation correction CT of 18F-FDG PET/CT in elderly Hodgkin lymphoma patients: a two-centre validation.

Authors:  Domenico Albano; Luca Camoni; Roberto Rinaldi; Alessandra Tucci; Vittorio Ruggero Zilioli; Cristina Muzi; Marco Ravanelli; Davide Farina; Alessandra Coppola; Manuela Camalori; Raffaele Giubbini; Francesco Bertagna
Journal:  Br J Radiol       Date:  2021-06-09       Impact factor: 3.039

6.  Establishment of normative biometric data for body composition based on computed tomography in a North American cohort.

Authors:  P J Navin; M R Moynagh; E J Atkinson; P Tirumanisetty; N K LeBrasseur; A Kumar; S Khosla; N Takahashi
Journal:  Clin Nutr       Date:  2020-10-29       Impact factor: 7.643

7.  Skeletal muscle cutoff values for sarcopenia diagnosis using T10 to L5 measurements in a healthy US population.

Authors:  Brian A Derstine; Sven A Holcombe; Brian E Ross; Nicholas C Wang; Grace L Su; Stewart C Wang
Journal:  Sci Rep       Date:  2018-07-27       Impact factor: 4.379

8.  Percentiles for skeletal muscle index, area and radiation attenuation based on computed tomography imaging in a healthy Caucasian population.

Authors:  A van der Werf; J A E Langius; M A E de van der Schueren; S A Nurmohamed; K A M I van der Pant; S Blauwhoff-Buskermolen; N J Wierdsma
Journal:  Eur J Clin Nutr       Date:  2017-12-15       Impact factor: 4.016

9.  Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy.

Authors:  Willemieke P M Dijksterhuis; Maarten J Pruijt; Stephanie O van der Woude; Remy Klaassen; Sophie A Kurk; Martijn G H van Oijen; Hanneke W M van Laarhoven
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-01-21       Impact factor: 12.910

10.  Associations between severe co-morbidity and muscle measures in advanced non-small cell lung cancer patients.

Authors:  Bjørn H Grønberg; Christine Damgaard Valan; Tarje Halvorsen; Bjørg Sjøblom; Marit S Jordhøy
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-08-06       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.